Clinical Trials Browser

Phase 2 × Breast Neoplasm Female × anlotinib × Clear all

NCT05075512 2021-10-12

The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer

Phase 2 Recruiting

Breast Neoplasm Female